Also, downregulation of the fibrotic genes (Type 1 collagen and α-SMA) and the growth factor (TGF-β1) expression, which was evaluated by quantitative RT-PCR, was significantly associated with the combination treatment more than that with the single treatment with AT-MSCs, indicating decreased hepatic fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.